Back to HALO Stock Lookup

HALO – Analyst PT Change

Oct 8, 2012 01:52 PM Wedbush Analysts Sees Halozyme (HALO) Stock at $17 Per Share
Aug 2, 2012 11:01 AM Jefferies Maintains a 'Buy' on ViroPharma (VPHM); Major Setback with SC Cinryze Using HALO Technology
Apr 17, 2012 08:30 AM Jefferies Cuts Numbers on Halozyme Therapeutics (HALO)
Apr 17, 2012 08:16 AM Wedbush Reiterates an 'Outperform' on Halozyme Therapeutics (HALO); Selloff Over Done, Several Positive Catalysts Ahead
Apr 16, 2012 01:04 PM Brean Murray Carret & Co. Maintains a 'Buy' on Halozyme Therapeutics (HALO); Oversold on HyQ News - Opportunity Heading Into Rituxan Phase 3

Back to HALO Stock Lookup